C50.019 Malignant neoplasm of nipple and areola, unspecified female breast. C50.02 Malignant neoplasm of nipple and areola, male. C50.021 Malignant neoplasm of nipple and areola, right male breast. C50.022 Malignant neoplasm of nipple and areola, left male breast.
Oct 01, 2021 · C50.912 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C50.912 became effective on October 1, 2021. This is the American ICD-10-CM version of C50.912 - other international versions of ICD-10 C50.912 may differ.
Oct 01, 2021 · C50.919 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Malignant neoplasm of unsp site of unspecified female breast. The 2022 edition of ICD-10-CM C50.919 became effective on …
Malignant neoplasm of axillary tail, right female breast. C50.811. Malignant neoplasm of overlapping sites, right female breast. C50.911. Malignant neoplasm of unspecified site, right female breast. D05.01. Lobular carcinoma in situ, right breast. D05.11. Intraductal carcinoma in situ, right breast.
FEMALE | |
---|---|
Right | |
C50.811 | Malignant neoplasm of overlapping sites, right female breast |
C50.911 | Malignant neoplasm of unspecified site, right female breast |
D05.01 | Lobular carcinoma in situ, right breast |
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
The code C50.912 is applicable to female patients only. It is clinically and virtually impossible to use this code on a non-female patient. Unspecified diagnosis codes like C50.912 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, ...
Breast cancer affects one in eight women during their lives. No one knows why some women get breast cancer, but there are many risk factors. Risks that you cannot change include
Age - the risk rises as you get older. Genes - two genes, BRCA1 and BRCA2, greatly increase the risk. Women who have family members with breast or ovarian cancer may wish to be tested for the genes. Personal factors - beginning periods before age 12 or going through menopause after age 55.
Hormone therapy for breast cancer (Medical Encyclopedia) [ Learn More in MedlinePlus ] Breast cancer Breast cancer is a disease in which certain cells in the breast become abnormal and multiply uncontrollably to form a tumor.
In both women and men, the most common form of breast cancer begins in cells lining the milk ducts (ductal cancer). In women, cancer can also develop in the glands that produce milk (lobular cancer).
C50.912 is a billable diagnosis code used to specify a medical diagnosis of malignant neoplasm of unspecified site of left female breast. The code C50.912 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.#N#The ICD-10-CM code C50.912 might also be used to specify conditions or terms like infiltrating duct carcinoma of bilateral female breasts, infiltrating duct carcinoma of left female breast, infiltrating duct carcinoma of right female breast, infiltrating lobular carcinoma of breast, infiltrating lobular carcinoma of left female breast , lump in bilateral breasts, etc.#N#The code C50.912 is applicable to female patients only. It is clinically and virtually impossible to use this code on a non-female patient.#N#Unspecified diagnosis codes like C50.912 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
The code C50.912 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions. The code C50.912 is applicable to female patients only. It is clinically and virtually impossible to use this code on a non-female patient.
Invasive carcinoma of no special type (NST) also known as invasive ductal carcinoma or ductal NOS and previously known as invasive ductal carcinoma, not otherwise specified (NOS) is a group of breast cancers that do not have the "specific differentiating features". Those that have these features belong to other types.
This is the official approximate match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that while there is no exact mapping between this ICD10 code D05.82 and a single ICD9 code, 233.0 is an approximate match for comparison and conversion purposes.